Skip to main content
ASRT
NASDAQ Life Sciences

预计Assertio Holdings每股亏损2.71美元，收入暴跌48.3%

feedReported by Reuters
Sentiment info
Negative
Importance info
7
Price
$11.54
Mkt Cap
$74.05M
52W Low
$7.706
52W High
$15.15
Market data snapshot near publication time

summarizeSummary

分析师预计Assertio Holdings, Inc.截至2025年12月31日的季度每股亏损将达到2.71美元。同时，预计季度收入将大幅下降48.3%，从去年的3.218亿美元暴跌至1.6626亿美元。这些负面预期来自可靠的新闻来源，对于像Assertio这样的公司规模来说具有重要意义，在3月16日正式公布财报之前设定了一个充满挑战的背景。交易者将密切关注实际结果与这些低预期的差异，因为任何偏差都可能引发显著的股票价格波动。

在该公告发布时，ASRT的交易价格为$11.54，交易所为NASDAQ，所属行业为Life Sciences，市值约为$7405万。 52周交易区间为$7.71至$15.15。 这则新闻被评估为消极市场情绪，重要性评分为7/10。 来源：Reuters。

show_chartPrice Chart

Share this article

Copied!

feed ASRT - Latest Insights

ASRT
Apr 21, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Assertio Holdings Announces April 29 Tender Offer Commencement for Garda Therapeutics Acquisition
Sentiment: Neutral
View Wiseek Article
ASRT
Apr 14, 2026, 4:41 PM EDT
Filing Type: 8-K
Importance Score:
8
Assertio Holdings Completes $35M Product Divestiture to Cosette Pharma, Bolstering Cash Ahead of Acquisition
Sentiment: Neutral
View Wiseek Article
ASRT
Apr 09, 2026, 8:09 AM EDT
Filing Type: SC TO-C
Importance Score:
9
Assertio Holdings Files Tender Offer Communication for $18/Share Cash Acquisition by Garda Therapeutics, Plus CVR
Sentiment: Positive
View Wiseek Article
ASRT
Apr 09, 2026, 8:07 AM EDT
Filing Type: 8-K
Importance Score:
10
Assertio to be Acquired by Garda Therapeutics for $18/Share Cash Plus CVR; Divests Non-Rolvedon Assets to Cosette for $35M Upfront
Sentiment: Positive
View Wiseek Article
ASRT
Apr 08, 2026, 5:10 PM EDT
Source: Reuters
Importance Score:
8
Assertio Divests Sympazan® and Other Products to Cosette Pharma
Sentiment: Neutral
View Wiseek Article
ASRT
Apr 08, 2026, 4:04 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Assertio Agrees to Be Acquired by Garda Therapeutics
Sentiment: Neutral
View Wiseek Article
ASRT
Apr 06, 2026, 5:26 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Shareholders to Vote on 6.2% Equity Plan Increase and Director Elections
Sentiment: Neutral
View Wiseek Article
ASRT
Mar 16, 2026, 5:07 PM EDT
Filing Type: 10-K
Importance Score:
8
Assertio Holdings Reports Increased Net Loss, Negative Cash Flow, and Details Reverse Stock Split
Sentiment: Negative
View Wiseek Article
ASRT
Mar 16, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
8
Assertio Holdings Reports Q4 Loss, Projects Significant FY2026 Adjusted EBITDA Growth
Sentiment: Neutral
View Wiseek Article
ASRT
Mar 13, 2026, 4:11 PM EDT
Source: Reuters
Importance Score:
7
Significant Loss of $2.71/Share, 48.3% Revenue Drop Expected for Assertio Holdings
Sentiment: Negative
View Wiseek Article